PMGC Holdings (ELAB) Net Equity Issued and Repurchased (2022 - 2025)

PMGC Holdings (ELAB) posted Net Equity Issued and Repurchased of $35409.0 for Q2 2025, down 97.61% sequentially from $1.5 million in Q1 2025.

PMGC Holdings (ELAB) Net Equity Issued and Repurchased (2022 - 2025) Analysis & Trends

PMGC Holdings has reported Net Equity Issued and Repurchased for 4 years, with the latest figure at $35409.0 in Q2 2025.

Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $35409.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $1.5 million (changed N/A YoY) and the FY2025 annual result came in at $3.0 million, down 56.74% from the prior year.
Net Equity Issued and Repurchased declined to $35409.0 in Q2 2025 per ELAB's latest filing, from $1.5 million in the prior quarter.
Over five years, Net Equity Issued and Repurchased peaked at $1.5 million in Q1 2025 and troughed at -$2.1 billion in Q4 2022.
A 4-year average of -$256.4 million and a median of $179499.0 in 2023 frame the typical range for Net Equity Issued and Repurchased.
The sharpest annual moves came in 2023 and 2024: Net Equity Issued and Repurchased soared 100.0% in 2023, then changed 0.0% in 2024.
Over 4 years, Net Equity Issued and Repurchased stood at -$2.1 billion in 2022, then jumped by 100.0% to -$1.0 in 2023, then changed by 0.0% to -$1.0 in 2024, then soared by 3541000.0% to $35409.0 in 2025.
According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $35409.0, $1.5 million, and -$1.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	49.20 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	PMGC Holdings	31.22 Mn	12.43 Mn	385,691.00	-

Download Data